Interim Analysis Suggests SARS-CoV-2 Vaccine Has 90% Efficacy Rate
NewsPharmaceutical company Pfizer and biotechnology company BioNTech have announced the first interim efficacy data from a large-scale trial evaluating BNT162b2, a vaccine candidate developed against SARS-CoV-2. Their press release indicates a vaccine efficacy rate of ~90% seven days after a second dose of the vaccine is administered, however the data is yet to be published.
Read moreMethod Identifies Llama Nanobodies With "Ultra-High" SARS-CoV-2 Neutralization Potency
NewsIn Science, researchers at the University of Pittsburgh School of Medicine describe a new method to extract tiny but extremely powerful SARS-CoV-2 antibody fragments from llamas, which could be fashioned into inhalable therapeutics with the potential to prevent and treat COVID-19.
Key Marker Helps Accelerate the Development of CMV Vaccines
NewsA research team has identified a key marker that will help speed effective vaccine designs for cytomegalovirus (CMV).
Read moreExploring Ways To Boost Immunotherapy Success for Stomach Cancer
NewsImmunotherapy for stomach cancer may work better if it is administered to the patient sooner, in the earlier stages of disease, and in combination with standard chemotherapy, a new study suggests.
Read moreScientists Use Gene Therapy To Regenerate Damaged Nerve Fibres
NewsIn a study published in Nature Communications, scientists tested whether the gene responsible for the production of a protein known as Protrudin could stimulate the regeneration of nerve cells and protect them from cell death after an injury.
Read moreCall in the T Cells When Waging War on Zika
NewsIn a new study, scientists at LJI report that the immune system’s T cells have the power to prevent Zika infection in mice.
Read moreGas Chromatography
ArticleIn this article, we bring together resources from the across the site on gas chromatography, how it works, its pairing with downstream techniques and what its applications are.
Read moreThe Coronavirus Pandemic
ArticleOn December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to what has become the COVID-19 pandemic.
Read moreICP-OES – ICP Chemistry, ICP-OES Analysis, Strengths and Limitations
ArticleInductively coupled plasma-optical emission spectroscopy (ICP-OES) is an analytical technique that is used to identify the atomic composition of a sample. In this article we will explore how the technique works, what it tells us, strengths, limitations and common problems, and how it compares to other techniques in this analytical niche.
Read moreThe Culture of Cell Culturing: Be Careful Not To Contaminate!
ArticleResearchers must consider a number of factors for in vitro experiments. Selecting the most appropriate cell line or primary culture for the project at hand is only the first step. Researchers must then be vigilant to prevent contaminating the culture, from the initial moments it is plated and all throughout consecutive passages.
Read moreCoronaviruses and Vaccine Design – A Conversation With Jason Kindrachuk
ArticleJason Kindrachuk is an assistant professor in the Department of Medical Microbiology & Infectious Diseases, University of Manitoba, Canada. Much of his research is directed towards the circulation, transmission and pathogenesis of emerging viruses that pose significant threats to human and animal health. Technology Networks recently had the pleasure of interviewing Kindrachuk to learn more about his work with coronaviruses and the development of a vaccine candidate against the novel coronavirus, SARS-CoV-2.
Read moreStay Up-to-Date With COVID-19 Vaccine Development
ArticleTechnology Networks is committed to keeping you updated with the latest research in this space. In this article, you'll find a curation of our latest COVID-19 vaccine-related content.
Read more